바이오테크 보도자료
-
- CSL Vifor and Travere Therapeutics announce EMA has accepted for review the Conditional Marketing Authorization application for sparsentan for the treatment of IgA Nephropathy
- CSL Vifor and Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that the EMA has accepted for review the Conditional Marketing Authorization (CMA) application for sparsentan for the treatment of IgAN...
- 2022년 08월 23일
-
- Takeda’s QDENGA®▼ (Dengue Tetravalent Vaccine [Live, Attenuated]) Approved in Indonesia for Use Regardless of Prior Dengue Exposure
- Takeda (TSE:4502/NYSE:TAK) today announced the company’s dengue vaccine, QDENGA® (Dengue Tetravalent Vaccine [Live, Attenuated]) (TAK-003), was approved by the Indonesia National Agency for Drug and Food Con...
- 2022년 08월 23일
-
- Medisca Unveils New Brand Identity and Corporate Positioning as Partners in Wellness
- After three successful decades of redefining, shaping, and informing the pharmaceutical compounding industry standard, Medisca is proud to unveil a new global brand identity and corporate positioning that re...
- 2022년 08월 23일
-
- Kapruvia® approved in Switzerland with additional regulatory decisions expected in H2 2022
- Vifor Fresenius Medical Care Renal Pharma (VFMCRP) and Cara Therapeutics, Inc. (Nasdaq: CARA) today announced that they have received approval for Kapruvia® from the Swiss Agency for Therapeutic Products (Sw...
- 2022년 08월 19일
-
- Tavneos® (avacopan) recommended by England’s NICE for the treatment of AAV (GPA/MPA)
- Vifor Fresenius Medical Care Renal Pharma (VFMCRP) is pleased to announce that England’s National Institute for Health and Care Excellence (NICE) has recommended Tavneos® in combination with a rituximab or c...
- 2022년 08월 18일
-
- Carbon Opportunities Fund Launches First-of-its-Kind Investment Platform to Issue Tokenized Carbon Credits
- The International Finance Corporation, Cultivo, Aspiration, and Chia Network, today announced the launch of the Carbon Opportunities Fund (the Fund), a global investment platform that will raise private capi...
- 2022년 08월 18일
-
- Black & Veatch Completes World’s First Commercial-Scale Alternative Animal Feed Production Facility
- With demand for protein from the world’s rapidly growing population expected to rise, commissioning is now underway at the world’s first industrial-scale FeedKind® facility in Chongqing, China. The facility,...
- 2022년 08월 18일
-
- Xlear Files Amended Answer to the Government’s Lawsuit on COVID-19 Statements; Provides Still More Data In Support of Xlear’s Use as Additional Layer of Protection
- Xlear has filed an Amended Answer in response to the U.S. Government’s lawsuit against the company. According to Nathan Jones, Xlear’s CEO, the Amended Answer serves three main purposes: First, it provides t...
- 2022년 08월 16일
-
- Semperis Strengthens Active Directory Protection in the Asia-Pacific Market with Expansion Plans Accelerated by Strategic Channel Appointment
- Semperis, the pioneer in identity-driven cyber resilience for enterprises accelerated expansion of its hybrid identity protection solutions in the Asia-Pacific region by bringing onboard Jacquie Young, a lea...
- 2022년 08월 11일
-
- SMART Modular Announces SMART Zefr Memory with Ultra-High Reliability Performance for Demanding Compute Applications
- SMART Modular Technologies, Inc. (“SMART”), a division of SGH (Nasdaq: SGH) and a global leader in memory solutions, solid-state drives, and hybrid storage products announces its SMART Zefr™ Memory, a propri...
- 2022년 08월 10일
-
- Ferring Announces U.S. FDA Advisory Committee Meeting for RBX2660 its Investigational Microbiota-Based Live Biotherapeutic
- Ferring Pharmaceuticals today announced that the Vaccines and Related Biological Products Advisory Committee (VRBPAC) of the U.S. Food and Drug Administration (FDA) will hold a meeting on September 22, 2022,...
- 2022년 08월 10일
-
- Kirin Holdings’ Long-term GHG Reduction Target Was Approved by the Science Based Targets[*1] Initiative Based on Science-based Net-zero Targets
- Kirin Holdings Company, Limited (Kirin Holdings) has been approved as the first world company in the food and beverage processing sector with science-based net-zero targets validated by SBTi [*2] in July 202...
- 2022년 08월 08일
-
- GenomOncology and Congenica Announce Collaborative Development of Novel Precision Oncology Solution
- Congenica, a UK-based digital health company that enables the rapid analysis and interpretation of genomic data, has selected the GenomOncology Precision Oncology Platform for the development of a novel grou...
- 2022년 08월 05일
-
- First half of 2022: Boehringer Ingelheim continues growth pace and strengthens research pipeline
- Boehringer Ingelheim, a leading research-driven biopharmaceutical company, continued to increase its supply of medicine to patients in the first half of 2022, as it expanded its research pipeline in an incre...
- 2022년 08월 04일
-
- SINOVAC COVID-19 Vaccine Approved for Use in Children Above 6 months of Age in Hong Kong
- Sinovac Biotech Ltd. (“SINOVAC” or the “Company”) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced that based on related clinical trials and studies of vaccination for loca...
- 2022년 08월 04일
전시회
